Clinical Trials
Braintumor Website

There are 32 trials:
Facility: University of Texas MD Anderson Cancer Center
NCT Trial Name# of Centers

NCT01432171

  Lacosamide for Seizure Prophylaxis in High-Grade Gliomas
13

NCT02423343

  A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, Hepatocellular Carcinoma, or Glioblastoma
10

NCT02798029

  Frameless Fractionated Stereotactic Radiation Therapy (FSRT) for Brain Mets Study
3

NCT01469247

  Diffuse Intrinsic Pontine Glioma (DIPG) Reirradiation (ReRT)
2

NCT01592968

  A Prospective Phase III Trial to Compare Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy
1

NCT01854554

  Glioblastoma Multiforme (GBM) Proton vs. Intensity Modulated Radiotherapy (IMRT)
1

NCT01619774

  An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor
1

NCT02165995

  Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery
1

NCT02231775

  Neoadjuvant and Adjuvant Dabrafenib and Trametinib in Patients With Clinical Stage III Melanoma (Combi-Neo)
1

NCT02271711

  Fourth Ventricle Infusions of Autologous Ex Vivo Expanded NK Cells in Children With Recurrent Posterior Fossa Tumors
1

NCT02337686

  Pharmacodynamic Study of Pembrolizumab in Patients With Recurrent Glioblastoma
1

NCT02420613

  Study of Suberoylanilide Hydroxamic Acid (SAHA) With Temsirolimus in Children With Diffuse Intrinsic Pontine Glioma (DIPG)
1

NCT02661282

  Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Glioblastoma (GBM) Patients
1

NCT02698254

  Pilot Trial of Dose-Volume Constraints for Reirradiation of Recurrent Brain Tumors
1

NCT02754544

  Using Electrocorticogram (ECoG) in Predicting Eloquent Cortex and Post-Op Functional Outcomes in Patients With Brain Tumors
1

NCT00950001

  Resection Bed Post-Surgical Stereotactic Radiosurgery (SRS)
1

NCT01067469

  Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
1

NCT01266031

  Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
1

NCT01332630

  TPI 287 in Breast Cancer Metastatic to the Brain
1

NCT01430351

  Phase I Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin for Post-Radiation Therapy (RT) Glioblastoma Multiforme (GBM)
1

NCT02885272

  Dual Time Point FDG PET-MR Imaging Optimization for the Evaluation of Glioblastoma
1

NCT02696993

  Trial of Nivolumab With Radiation or Nivolumab and Ipilimumab With Radiation for the Treatment of Intracranial Metastases From Non-Small Cell Lung Cancer
1

NCT02717962

  Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
1

NCT03028337

  Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases
1

NCT01624766

  Anakinra or Denosumab and Everolimus in Advanced Cancer
1

NCT03174197

  Atezolizumab (aPDL1) + Temozolomide and Radiation for Newly Diagnosed Glioblastoma (GBM)
1

NCT03175432

  Study of BEvacizumab in Combination With ATezolizumab in Patients With Untreated Melanoma Brain Metastases
1

NCT03217747

  Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies
1

NCT03244995

  An Online Dyadic Mind-Body Intervention for Glioma Patients and Their Partners
1

NCT03022578

  Study of Laser Interstitial Thermal Therapy (LITT) in Recurrent Glioblastoma
1

NCT03430882

  TAK228 With Carbo and Taxol in Advanced Malignancies
1

NCT03458676

  Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites